106 related articles for article (PubMed ID: 10726390)
1. [Finally anti-inflammatory agents less damaging to the stomach?].
Piqué JM
Gastroenterol Hepatol; 2000 Feb; 23(2):87-9. PubMed ID: 10726390
[No Abstract] [Full Text] [Related]
2. The future of NSAID therapy: selective COX-2 inhibitors.
Vane JR; Botting RM
Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
[No Abstract] [Full Text] [Related]
3. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
Wigand R
Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
[No Abstract] [Full Text] [Related]
4. NSAIDs and alcohol: never the twain shall mix?
Pfau PR; Lichenstein GR
Am J Gastroenterol; 1999 Nov; 94(11):3098-101. PubMed ID: 10566697
[No Abstract] [Full Text] [Related]
5. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
Hawkey CJ
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265
[No Abstract] [Full Text] [Related]
6. [New anti-inflammatory analgetics--are they needed?].
Paakkari I
Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
[No Abstract] [Full Text] [Related]
7. [Pharmacological bases of non-steroidal anti-inflammatory analgesics].
Beltrán B; Moreno L; Esplugues JV
Gastroenterol Hepatol; 1996 Nov; 19(9):478-88. PubMed ID: 8998674
[No Abstract] [Full Text] [Related]
8. [What's in the future? New NSAIDs].
Laufer S
Pharm Unserer Zeit; 2002; 31(2):164-9. PubMed ID: 11977452
[No Abstract] [Full Text] [Related]
9. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?].
Kankaanranta H; Vapaatalo H
Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604
[No Abstract] [Full Text] [Related]
10. A magic bullet for mucosal protection...and aspirin is the trigger!
Wallace JL; Fiorucci S
Trends Pharmacol Sci; 2003 Jul; 24(7):323-6. PubMed ID: 12871661
[No Abstract] [Full Text] [Related]
11. Overview of nimesulide.
Bennett A
Rheumatology (Oxford); 1999 May; 38 Suppl 1():1-3. PubMed ID: 10369398
[No Abstract] [Full Text] [Related]
12. [Current post-marketing information. Effects and adverse effects of celecoxib].
Schmidt H; Geisslinger G
Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454
[No Abstract] [Full Text] [Related]
13. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
Hinz B; Brune K
MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
[No Abstract] [Full Text] [Related]
14. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
15. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
Wynn RL
Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
[No Abstract] [Full Text] [Related]
16. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
17. Mechanism of action of acetaminophen: is there a cyclooxygenase 3?
Botting RM
Clin Infect Dis; 2000 Oct; 31 Suppl 5():S202-10. PubMed ID: 11113024
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds.
Momin RA; De Witt DL; Nair MG
Phytother Res; 2003 Sep; 17(8):976-9. PubMed ID: 13680840
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity.
Kim BH; Chung EY; Min BK; Lee SH; Kim MK; Min KR; Kim Y
Planta Med; 2003 May; 69(5):474-6. PubMed ID: 12802736
[TBL] [Abstract][Full Text] [Related]
20. Wolf in sheep's clothing?
Varga J
Am J Hosp Palliat Care; 2000; 17(4):280. PubMed ID: 11883807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
